Concord Drugs Ltd Stock Price: Concord Drugs Share Price Today

Concord Drugs Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹30.28

Prev. Close

₹30.13

Turnover(Lac.)

₹0.18

Day's High

₹30.28

Day's Low

₹29.22

52 Week's High

₹44.96

52 Week's Low

₹26.1

Book Value

₹33.88

Face Value

₹10

Mkt Cap (₹ Cr.)

29.22

P/E

EPS

Divi. Yield

Concord Drugs Ltd Corporate Action

4 Mar 2025

12:00 AM

Board Meeting

Agenda : Audited Result

18 Sep 2024

12:00 AM

AGM

Announcement Date: 18 Sep, 2024

18 Sep 2024

12:00 AM

BookCloser

Concord Drugs Ltd NEWS AND UPDATE

No Record Found

Y/e 31 Mar( In .Cr)	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Equity Capital	10	9.88	8.74	8.74
Preference Capital	0	0	0	0
Reserves	23.82	21.82	19.62	18.02
Net Worth	33.82	31.7	28.36	26.76
Minority Interest

Y/e 31 Mar( In .Cr)	Mar-2021	Mar-2020	Mar-2018	Mar-2017
Revenue	51.35	51.33	51.79	57.48
yoy growth (%)	0.03	-0.88	-9.9	13.43
Raw materials	-42.17	-42.57	-43.29	-46.1
As % of sales	82.12	82.93	83.59	80.19
Employee costs	-3.75	-3.5	-1.97	-2.8

Y/e 31 Mar( In .Cr)	Mar-2021	Mar-2020	Mar-2018	Mar-2017
Profit before tax	0.52	0.45	0.63	0.64
Depreciation	-1.36	-1.46	-2.4	-2.58
Tax paid	-1.01	-0.12	-0.31	-0.48
Working capital	5.74	1.76	11.4	-13.41
Other operating items

Y/e 31 Mar	Mar-2021	Mar-2020	Mar-2018	Mar-2017
Growth matrix (%)
Revenue growth	0.03	-0.88	-9.9	13.43
Op profit growth	-3.71	-30.16	-13.02	-33.22
EBIT growth	-2.55	-20.71	-16.11	-45.68
Net profit growth	899.6	1.23	103.25	-90.87

Particulars (Rupees in Crores.)	Mar-2024	Mar-2023	Mar-2022
Gross Sales	44.92	52.08	58.96
Excise Duty	0	0	0
Net Sales	44.92	52.08	58.96
Other Operating Income	0.01	0.01	0.1
Other Income	0	0	0

Concord Drugs Ltd Peer Comparison

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceutical Industries Ltd SUNPHARMA	1,766.2	134.52	4,23,770.54	1,181.05	0.76	5,985.33	98.33
Divis Laboratories Ltd DIVISLAB	5,958.35	76.3	1,58,175.47	594	0.5	2,297	513.62
Cipla Ltd CIPLA	1,486.75	25.8	1,20,075.94	1,438.15	0.87	4,134.87	360.72
Torrent Pharmaceuticals Ltd TORNTPHARM	3,183	59.05	1,07,722.35	485	0.88	2,330	222.38
Mankind Pharma Ltd MANKIND	2,434.1	51.93	1,00,425.74	416.38	0	2,396.57	334.17

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Concord Drugs Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

S Nagi Reddy

Independent Director

K Ramchandra Reddy

Whole Time Director & CFO

Koni Reddy

Independent Director

S. Nagavenkata Hareesh

Whole-time Director

S. Manoj Kumar Reddy

Independent Director

Summela Kasu

Company Sec. & Compli. Officer

Namratha Nagla

Registered Office

Tel: -

Website: -

Email: -

Registrar Office

Tel: -

Website: -

Email: -

Reports by Concord Drugs Ltd

Summary

Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality.The Company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing Formulation-Fill-Finish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.
Read More

Company FAQs

What is the Concord Drugs Ltd share price today?

The Concord Drugs Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹29.22 today.

What is the Market Cap of Concord Drugs Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Concord Drugs Ltd is ₹29.22 Cr. as of 09 May ‘25

What is the PE and PB ratio of Concord Drugs Ltd?

The PE and PB ratios of Concord Drugs Ltd is 0 and 0.89 as of 09 May ‘25

What is the 52 Week High and Low of Concord Drugs Ltd?

The 52-week high/low is the highest and lowest price at which a Concord Drugs Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Concord Drugs Ltd is ₹26.1 and ₹44.96 as of 09 May ‘25

What is the CAGR of Concord Drugs Ltd?

Concord Drugs Ltd's CAGR for 5 Years at 11.54%, 3 Years at 2.17%, 1 Year at -15.86%, 6 Month at -21.90%, 3 Month at -14.89% and 1 Month at -2.18%.

What is the shareholding pattern of Concord Drugs Ltd?

The shareholding pattern of Concord Drugs Ltd is as follows:
Promoters - 54.39 %
Institutions - 0.00 %
Public - 45.61 %

Concord Drugs Ltd Share Price

Equities

Futures

Option

Concord Drugs Ltd KEY RATIOS

Concord Drugs Ltd Corporate Action

Concord Drugs Ltd NEWS AND UPDATE

Knowledge Center

Demat Account

Trading Account

Concord Drugs Ltd SHAREHOLDING SNAPSHOT

Promoter- 54.39%

Non-Promoter- 45.60%

Concord Drugs Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Concord Drugs Ltd Peer Comparison

MORE ABOUT Concord Drugs Ltd

Management

Register Office

Registrar Office

Company FAQs

QUICKLINKS FOR Concord Drugs Ltd

Information

Financials

Results

News

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES